Clinical Trial Update: Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects

View source ↗

Summary

The trial assesses the optimal cut-off value of PEA measured by the Corsens Device to distinguish myocardial infarction from non-MI subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Corsens Medical LTD | Conditions: Myocardial Infarction | Status: UNKNOWN